144 related articles for article (PubMed ID: 21943969)
1. Screening for colorectal cancer: sense and sensibilities.
Van Hal G; Hoeck S; Van Roosbroeck S
Eur J Cancer; 2011 Sep; 47 Suppl 3():S156-63. PubMed ID: 21943969
[TBL] [Abstract][Full Text] [Related]
2. Population-based screening for colorectal cancer using an immunochemical faecal occult blood test: a comparison of two invitation strategies.
Van Roosbroeck S; Hoeck S; Van Hal G
Cancer Epidemiol; 2012 Oct; 36(5):e317-24. PubMed ID: 22560885
[TBL] [Abstract][Full Text] [Related]
3. What influences the decision to participate in colorectal cancer screening with faecal occult blood testing and sigmoidoscopy?
van Dam L; Korfage IJ; Kuipers EJ; Hol L; van Roon AH; Reijerink JC; van Ballegooijen M; van Leerdam ME
Eur J Cancer; 2013 Jul; 49(10):2321-30. PubMed ID: 23571149
[TBL] [Abstract][Full Text] [Related]
4. Screening for colorectal cancer: comparison of perceived test burden of guaiac-based faecal occult blood test, faecal immunochemical test and flexible sigmoidoscopy.
Hol L; de Jonge V; van Leerdam ME; van Ballegooijen M; Looman CW; van Vuuren AJ; Reijerink JC; Habbema JD; Essink-Bot ML; Kuipers EJ
Eur J Cancer; 2010 Jul; 46(11):2059-66. PubMed ID: 20621736
[TBL] [Abstract][Full Text] [Related]
5. Feasibility of immunochemical faecal occult blood testing for colorectal cancer screening in Bulgaria.
Tsvetanova Dimova R; Dimitrova Dimitrova D; Angelova Levterova B; Stoyanov Dimov R; Atanasova Semerdjieva M; Frantova Tarnovska M; Gencheva Stoyanova R
J BUON; 2015; 20(2):413-20. PubMed ID: 26011330
[TBL] [Abstract][Full Text] [Related]
6. Low priority main reason not to participate in a colorectal cancer screening program with a faecal occult blood test.
van Rijn AF; van Rossum LG; Deutekom M; Laheij RJ; Fockens P; Bossuyt PM; Dekker E; Jansen JB
J Public Health (Oxf); 2008 Dec; 30(4):461-5. PubMed ID: 18716047
[TBL] [Abstract][Full Text] [Related]
7. Most participate in faecal immunochemical test-based colorectal cancer screening out of curiosity about their chances of developing cancer.
Denters MJ; Bossuyt PM; Deutekom M; Fockens P; Dekker E
Eur J Cancer Prev; 2015 May; 24(3):176-9. PubMed ID: 25734239
[TBL] [Abstract][Full Text] [Related]
8. Would general practitioners support a population-based colorectal cancer screening programme of faecal-occult blood testing?
Tong S; Hughes K; Oldenburg B; Del Mar C
Intern Med J; 2004; 34(9-10):532-8. PubMed ID: 15482265
[TBL] [Abstract][Full Text] [Related]
9. Preferences for colorectal cancer screening techniques and intention to attend: a multi-criteria decision analysis.
Hummel JM; Steuten LG; Groothuis-Oudshoorn CJ; Mulder N; Ijzerman MJ
Appl Health Econ Health Policy; 2013 Oct; 11(5):499-507. PubMed ID: 23979875
[TBL] [Abstract][Full Text] [Related]
10. Adding familial risk assessment to faecal occult blood test can increase the effectiveness of population-based colorectal cancer screening.
Dekker N; van Rossum LG; Van Vugt-van Pinxteren M; van Stiphout SH; Hermens RP; van Zelst-Stams WA; van Oijen MG; Laheij RJ; Jansen JB; Hoogerbrugge N
Eur J Cancer; 2011 Jul; 47(10):1571-7. PubMed ID: 21367600
[TBL] [Abstract][Full Text] [Related]
11. Round one of the Adelaide and Meath Hospital/Trinity College Colorectal Cancer Screening Programme: programme report and analysis based on established international key performance indices.
McNamara D; Qasim A; Lee N; Condon C; O'Morain C
Ir J Med Sci; 2011 Jun; 180(2):549-52. PubMed ID: 21264524
[TBL] [Abstract][Full Text] [Related]
12. Eliciting population preferences for mass colorectal cancer screening organization.
Nayaradou M; Berchi C; Dejardin O; Launoy G
Med Decis Making; 2010; 30(2):224-33. PubMed ID: 19692710
[TBL] [Abstract][Full Text] [Related]
13. Comparing different strategies for colorectal cancer screening in Italy: predictors of patients' participation.
Senore C; Armaroli P; Silvani M; Andreoni B; Bisanti L; Marai L; Castiglione G; Grazzini G; Taddei S; Gasperoni S; Giuliani O; Malfitana G; Marutti A; Genta G; Segnan N
Am J Gastroenterol; 2010 Jan; 105(1):188-98. PubMed ID: 19826409
[TBL] [Abstract][Full Text] [Related]
14. Faecal immunochemical test-based colorectal cancer screening programme SVIT in Slovenia: pilot phase.
Tepeš B; Stabuc B; Stefanovič M; Bračko M; Frkovič Grazio S; Novak Mlakar D; Maučec Zakotnik J
Eur J Cancer Prev; 2014 Jul; 23(4):235-9. PubMed ID: 24030444
[TBL] [Abstract][Full Text] [Related]
15. Involvement of previous non-participants cannot fully compensate for lower participation in a second round of FIT-screening.
Denters MJ; Deutekom M; Bossuyt PM; van Rijn AF; Fockens P; Dekker E
Cancer Epidemiol; 2013 Jun; 37(3):330-5. PubMed ID: 23403127
[TBL] [Abstract][Full Text] [Related]
16. Colorectal cancer screening with faecal occult blood test within a multiple disease screening programme: an experience from Keelung, Taiwan.
Yang KC; Liao CS; Chiu YH; Yen AM; Chen TH
J Med Screen; 2006; 13 Suppl 1():S8-13. PubMed ID: 17227635
[TBL] [Abstract][Full Text] [Related]
17. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.
Segnan N; Senore C; Andreoni B; Arrigoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; DiPlacido R; Ferrari A; Ferraris R; Ferrero F; Fracchia M; Gasperoni S; Malfitana G; Recchia S; Risio M; Rizzetto M; Saracco G; Spandre M; Turco D; Turco P; Zappa M;
J Natl Cancer Inst; 2005 Mar; 97(5):347-57. PubMed ID: 15741571
[TBL] [Abstract][Full Text] [Related]
18. [Colorectal cancer screening: advice from the Health Council of the Netherlands].
van Veen W; Mali WP
Ned Tijdschr Geneeskd; 2009; 153():A1441. PubMed ID: 20003552
[TBL] [Abstract][Full Text] [Related]
19. To participate or not? Giving voice to gender and socio-economic differences in colorectal cancer screening programmes.
Molina-Barceló A; Salas Trejo D; Peiró-Pérez R; Málaga López A
Eur J Cancer Care (Engl); 2011 Sep; 20(5):669-78. PubMed ID: 21771129
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness analysis for determining optimal cut-off of immunochemical faecal occult blood test for population-based colorectal cancer screening (KCIS 16).
Chen LS; Liao CS; Chang SH; Lai HC; Chen TH
J Med Screen; 2007; 14(4):191-9. PubMed ID: 18078564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
